cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.15468/dl.uutpnc
title: Occurrence Download

description: A dataset listing the 2662 species recorded in GBIF matching the query:
{
 "and" : [
 "Country is Russian Federation",
 "OccurrenceStatus is Present",
 "TaxonKey is Araneae"
 ]
}

 The dataset's 2662 records were derived from 85 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0019545-240506114902167/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.25402/fca.19122020
title: Supplementary Table 1: Diagnostic accuracy of coronary computed tomography angiography in ischemic workup of heart failure: a meta-analysis.docx

description: Figures depicting publication
bias detected for patient-based analysis and Quality assessment of included studies using
the QUADAS-2 tool
DOI: 10.15468/dl.agy74u
title: Occurrence Download

description: A dataset containing 2 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is BOLD:AAY3673"
 ]
}

 The dataset includes 2 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0019560-240506114902167/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.25402/fca.19122923
title: Supplementary Table 1: CT coronary angiography as the non-invasive in stable coronary artery disease? Long-term outcomes meta-analysis.docx

description: Images depicting risk
of bias and main outcomes of the meta-analysis, with table summarizing aims and
endpoints of the included studies.
DOI: 10.25402/fca.19596775
title: Supplementary table 1: Aortic valve intervention for aortic stenosis and cardiac amyloidosis: a systematic review and meta-analysis.docx

description: Supplementary Table 1.
DOI: 10.25402/fsg.20037077
title: Supplementary material: Association of GDF-15, hs-cTnT and NT-proBNP with coronary artery disease in patients undergoing elective angiography

description: Supplementary material: Association of GDF-15, hs-cTnT and NT-proBNP with coronary artery disease in patients undergoing elective angiography
DOI: 10.25402/fca.20131940
title: Supplemental Table 1: The top 50 most cited articles on cardiac tumors: a bibliometric analysis.docx

description:      
<strong>Supplemental table 1. Top 50 original   articles on cardiac tumors</strong>
DOI: 10.25402/fca.20230629
title: Supplementary Materials: Colchicine for cardiovascular medicine: a systematic review and meta-analysis.

description:       
<strong>Supplementary Figure S1.</strong> PRISMA flow diagram.
<br>
<strong>Table S1.</strong> PRISMA Checklist.
DOI: 10.25402/fsg.20792224
title: Supplementary Table 1: Inpatient palliative care encounter and 30-day readmission among hospitalizations for heart failure.docx

description:      
<strong>Supplemental Table 1.</strong> Characteristics and the Unadjusted Odds of 30-Day Readmission
DOI: 10.25402/fca.20792995
title: Supplementary Tables 1 and 2: Analysis of severity in ischemic stroke patients with coronary artery disease in the telestroke network.docx

description: Supplementary Tables 1 and 2: Analysis of severity in ischemic stroke patients with coronary artery disease in the telestroke network
DOI: 10.25402/fca.21062944
title: Supplementary Material 2: Outcomes in cardiac implantable electronic device-related infective endocarditis: a systematic review of current literature.docx

description:   
<strong>Supplementary material 2. </strong>The complete search strategy per database
DOI: 10.25402/fca.21062947
title: Supplementary Material 1: Outcomes in cardiac implantable electronic device-related infective endocarditis: a systematic review of current literature.docx

description: PRISMA checklist
DOI: 10.25402/fca.21062950
title: Supplementary Table 1: Outcomes in cardiac implantable electronic device-related infective endocarditis: a systematic review of current literature.docx

description:   
<strong>Supplementary Table 1: The 35 included studies</strong>
DOI: 10.25402/fca.21205931
title: Supplementary material: Real-world treatment patterns and stroke risks among patients with atrial fibrillation in China.docx

description:   
<strong>Supplementary Table 1.</strong> Types of medications used by patients in the study
<br>
  
<strong>Supplementary Table 2</strong>. List of ICD-9-CM and ICD-10-CM codes used to identify stroke
<br>
  
<strong>Supplementary Table 3</strong>. Sensitivity analysis for patients with continuity of EMRs for ≥6 months after the index date
<br>
  
<strong>Supplementary Table 4</strong>. Sensitivity analysis for patients treated with antiplatelet medication
<br>
  
<strong>Supplementary Table 5.</strong> Univariate and multivariate Cox regression analysis for stroke risk by CHA2DS2-VASc score
DOI: 10.25402/fca.21205931.v1
title: Supplementary material: Real-world treatment patterns and stroke risks among patients with atrial fibrillation in China.docx

description:   
<strong>Supplementary Table 1.</strong> Types of medications used by patients in the study
<br>
  
<strong>Supplementary Table 2</strong>. List of ICD-9-CM and ICD-10-CM codes used to identify stroke
<br>
  
<strong>Supplementary Table 3</strong>. Sensitivity analysis for patients with continuity of EMRs for ≥6 months after the index date
<br>
  
<strong>Supplementary Table 4</strong>. Sensitivity analysis for patients treated with antiplatelet medication
<br>
  
<strong>Supplementary Table 5.</strong> Univariate and multivariate Cox regression analysis for stroke risk by CHA2DS2-VASc score
DOI: 10.15468/dl.ngumng
title: Occurrence Download

description: A dataset containing 154 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Pinnixa occidentalis Rathbun, 1894"
 ]
}

 The dataset includes 154 records from 16 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0019561-240506114902167/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.25402/fca.21602820
title: Supplementary Table 1: The top 100 cited articles on spontaneous coronary artery dissection: a bibliometric analysis.docx

description:      
<strong>Supplementary Table 1. Rank order of articles by citation density</strong>
DOI: 10.25402/fca.23514564
title: Acute myopericarditis due to human granulocytic anaplasmosis supplementary materials

description: We present a case of a 54-year-old gentleman with a history of hypertension and chronic HIV who
presented with fever and epigastric pain, found to have elevated troponin-I levels and diffuse STsegement
elevations on ECG without clinical evidence of ischemia concerning for myopericarditis. Initial
laboratory findings also included thrombocytopenia and elevated aminotransferases as well as computed
tomography imaging revealing splenic infarcts. Given plausible exposure to ticks, this led to the eventual
diagnosis of anaplasmosis confirmed on PCR assay. CardiacMRI images confirmed myocardial involvement,
which resolved with antibiotic treatment. While rare, cardiac involvement is possible sequelae of
anaplasmosis infection as illustrated by this case.
DOI: 10.25402/fca.23514564.v1
title: Acute myopericarditis due to human granulocytic anaplasmosis supplementary materials

description: We present a case of a 54-year-old gentleman with a history of hypertension and chronic HIV who
presented with fever and epigastric pain, found to have elevated troponin-I levels and diffuse STsegement
elevations on ECG without clinical evidence of ischemia concerning for myopericarditis. Initial
laboratory findings also included thrombocytopenia and elevated aminotransferases as well as computed
tomography imaging revealing splenic infarcts. Given plausible exposure to ticks, this led to the eventual
diagnosis of anaplasmosis confirmed on PCR assay. CardiacMRI images confirmed myocardial involvement,
which resolved with antibiotic treatment. While rare, cardiac involvement is possible sequelae of
anaplasmosis infection as illustrated by this case.
DOI: 10.17632/cztn6c4mtj.1
title: Data for article "Regeneration niche of Cortaderia selloana in an invaded region: flower predation, environmental stress, and transgenerational effects"

description: Germination, growth, and survival data.
DOI: 10.25402/fca.23684487
title: Hyperacute synchronous cardiocerebral infarction in a patient with new-onset atrial fibrillation: a case of myocardial infarction with nonobstructive coronary arteries Supplementary data

description: Hyperacute synchronous cardiocerebral infarction (CCI) is an extremely rare condition with an incidence of
0.009%. In the acute stage of ischemic stroke, there is a high prevalence of ECG abnormalities. Prolonged
QTc, atrial fibrillation (AF) and ECG changes indicative of ischemic heart disease, such as Q waves, ST
depression, and T wave inversion, were the most prevalent changes. There are three types of simultaneous
CCI: cardiac conditions that cause cerebral infarction, cerebral infarction caused by cardiac conditions, and
(c) dysregulation of the brain–heart axis or cerebral infarction causing myocardial infarction. Herein, we
present a case of hyperacute synchronous CCI in an elderly patient with new-onset AF and myocardial
infarction with nonobstructive coronary arteries (MINOCA).
DOI: 10.25402/fca.23684487.v1
title: Hyperacute synchronous cardiocerebral infarction in a patient with new-onset atrial fibrillation: a case of myocardial infarction with nonobstructive coronary arteries Supplementary data

description: Hyperacute synchronous cardiocerebral infarction (CCI) is an extremely rare condition with an incidence of
0.009%. In the acute stage of ischemic stroke, there is a high prevalence of ECG abnormalities. Prolonged
QTc, atrial fibrillation (AF) and ECG changes indicative of ischemic heart disease, such as Q waves, ST
depression, and T wave inversion, were the most prevalent changes. There are three types of simultaneous
CCI: cardiac conditions that cause cerebral infarction, cerebral infarction caused by cardiac conditions, and
(c) dysregulation of the brain–heart axis or cerebral infarction causing myocardial infarction. Herein, we
present a case of hyperacute synchronous CCI in an elderly patient with new-onset AF and myocardial
infarction with nonobstructive coronary arteries (MINOCA).
DOI: 10.17632/vftc3325y8.1
title: Effect of antiepileptic drug monotherapy on endogenous sex hormonal profile in men and women with epilepsy

description: Supporting information for the systematic review and meta-analysis conducted for elucidating the effect antiepileptic drug monotherapy on endogenous sex hormonal profile in men and women with epilepsy.
DOI: 10.17632/w9fks3d5sp.1
title: Zircon U-Pb-Hf data from various microplatforms in SE Asia

description: This dataset collects and organizes the zircon U-Pb-Hf data of Borneo microcrops and parts of NW Australia that have been published by the previous authors. Table 'information_SE Asia and Aus' is mainly used to store the basic information of the collected samples, table 'data_SE Asia and Aus' is mainly used to store zircon U-Pb age data of the samples, and table 'Hf' is mainly used to store zircon Hf isotope data of the samples.
DOI: 10.25402/fca.24017022
title: Reduced heart failure-related healthcare costs with Furoscix versus in-hospital intravenous diuresis in heart failure patients: the FREEDOM-HF study - supplementary table

description: <b>Aim: </b>Compare heart failure (HF) costs of Furoscix use at home compared with inpatient intravenous (IV) diuresis. <b>Patients & methods: </b>Prospective, case control study of chronic HF patients presenting to emergency department (ED) with worsening congestion discharged to receive Furoscix 80 mg<b>/</b>10 ml 5- h subcutaneous infusion for <b>≤</b>7 days. 30-day HF-related costs in Furoscix group derived from commercial claims database compared with matched historical patients hospitalized for <b>&lt;</b>72 h. <b>Results: </b>Of 24 Furoscix patients, 1 (4.2%) was hospitalized in 30-day period. Sixty-six control patients identified and were wellmatched for age, sex, ejection fraction (EF), renal function and other comorbidities. Furoscix patients had reduced mean per patient HF-related healthcare cost of $16,995 (p <b>&lt; </b>0.001). <b>Conclusion: </b>Furoscix use was associated with significant reductions in 30-day HF-related healthcare costs versus matched hospitalized controls.
DOI: 10.25402/fca.24017022.v1
title: Reduced heart failure-related healthcare costs with Furoscix versus in-hospital intravenous diuresis in heart failure patients: the FREEDOM-HF study - supplementary table

description: <b>Aim: </b>Compare heart failure (HF) costs of Furoscix use at home compared with inpatient intravenous (IV) diuresis. <b>Patients & methods: </b>Prospective, case control study of chronic HF patients presenting to emergency department (ED) with worsening congestion discharged to receive Furoscix 80 mg<b>/</b>10 ml 5- h subcutaneous infusion for <b>≤</b>7 days. 30-day HF-related costs in Furoscix group derived from commercial claims database compared with matched historical patients hospitalized for <b>&lt;</b>72 h. <b>Results: </b>Of 24 Furoscix patients, 1 (4.2%) was hospitalized in 30-day period. Sixty-six control patients identified and were wellmatched for age, sex, ejection fraction (EF), renal function and other comorbidities. Furoscix patients had reduced mean per patient HF-related healthcare cost of $16,995 (p <b>&lt; </b>0.001). <b>Conclusion: </b>Furoscix use was associated with significant reductions in 30-day HF-related healthcare costs versus matched hospitalized controls.
DOI: 10.25402/nnm.24064857
title: Phenotype-directed clinically driven low-dose direct oral anticoagulant for atrial fibrillation - supplementary file

description: Clinically-driven dose reduction of direct oral anticoagulants in individuals with atrial fibrillation is prevalent worldwide. However, a paucity of evidence to tailor dose selection remained as clinical unmet need. Current doses of anticoagulant were determined largely by landmark clinical trials, in which the enrolled subjects were carefully selected and without major comorbidities. Our study reviewed the relevant real-world studies in specific patient phenotypes, including renal and hepatic diseases, elderly, low body weight, Asians and presence of concomitant drug–drug interactions. Thorough investigations toward the efficacy and safety of direct oral anticoagulants in reduced doses will facilitate substituting current universal approach with individualized prescriptions.
DOI: 10.25402/nnm.24064857.v1
title: Phenotype-directed clinically driven low-dose direct oral anticoagulant for atrial fibrillation - supplementary file

description: Clinically-driven dose reduction of direct oral anticoagulants in individuals with atrial fibrillation is prevalent worldwide. However, a paucity of evidence to tailor dose selection remained as clinical unmet need. Current doses of anticoagulant were determined largely by landmark clinical trials, in which the enrolled subjects were carefully selected and without major comorbidities. Our study reviewed the relevant real-world studies in specific patient phenotypes, including renal and hepatic diseases, elderly, low body weight, Asians and presence of concomitant drug–drug interactions. Thorough investigations toward the efficacy and safety of direct oral anticoagulants in reduced doses will facilitate substituting current universal approach with individualized prescriptions.
DOI: 10.25402/fca.24278692
title: Mitral valve geometrical echocardiographic analysis and 3D computational modeling of a normal mitral valve - supplementary material

description: <b>Aim: </b>This research aims to develop a consistent computational model of a normal mitral valve (MV) and describe mitral regurgitation (MR) geometry based on Carpentier’s classification. <b>Materials &methods:</b>MV geometry was assessed by 2D transthoracic echocardiogram in 100 individuals. A 3D parametric geometric model of the MV was developed. A computational model of a normal MV was performed. <b>Results: </b>The simulation of the valve function was successfully accomplished and its kinematics was analyzed. Differences in geometry were revealed between normal and type III MR. <b>Conclusion: </b>3D computational models of the normal MV can be constructed relying on standard measurements performed by 2D echocardiography. Certain geometrical differences exist among the normal and the most severe type of MR.<b>Plain language summary: </b>Mitral insufficiency, represents the most common form of valvular heart disease and occurs when the mitral valve does not close tight causing blood to flow the wrong way in the heart. The simplest and most usual method to evaluate this dysfunction is the 2D transthoracic echocardiography, which uses ultrasound to create images of the heart. Mitral insufficiency can be classified into three types. This study tried to evaluate any differences in the clinical and<b>/</b>or echocardiographic geometrical characteristics between the normal MV and the three types of insufficient MV. Moreover, it tried to develop a 3D model to simulate the normal MV function. To achieve this, it enrolled 100 individuals (both normal and insufficientMV), evaluated theirMV with 2D echocardiography and compared all geometrical characteristics between them. Finally, computational simulation, using specific and appropriate methods, was used to create the 3D model. Regarding the results, the most differences were found between subjects with normal and subjects with type III mitral insufficiency. Moreover, a 3D model of the normal MV was successfully developed. To conclude, there are specific geometrical differences among the normal and the most severe type of the insufficient MV, while 3D models of the normal MV can be developed by 2D echocardiography measurements.
DOI: 10.25402/fca.24278692.v1
title: Mitral valve geometrical echocardiographic analysis and 3D computational modeling of a normal mitral valve - supplementary material

description: <b>Aim: </b>This research aims to develop a consistent computational model of a normal mitral valve (MV) and describe mitral regurgitation (MR) geometry based on Carpentier’s classification. <b>Materials &methods:</b>MV geometry was assessed by 2D transthoracic echocardiogram in 100 individuals. A 3D parametric geometric model of the MV was developed. A computational model of a normal MV was performed. <b>Results: </b>The simulation of the valve function was successfully accomplished and its kinematics was analyzed. Differences in geometry were revealed between normal and type III MR. <b>Conclusion: </b>3D computational models of the normal MV can be constructed relying on standard measurements performed by 2D echocardiography. Certain geometrical differences exist among the normal and the most severe type of MR.<b>Plain language summary: </b>Mitral insufficiency, represents the most common form of valvular heart disease and occurs when the mitral valve does not close tight causing blood to flow the wrong way in the heart. The simplest and most usual method to evaluate this dysfunction is the 2D transthoracic echocardiography, which uses ultrasound to create images of the heart. Mitral insufficiency can be classified into three types. This study tried to evaluate any differences in the clinical and<b>/</b>or echocardiographic geometrical characteristics between the normal MV and the three types of insufficient MV. Moreover, it tried to develop a 3D model to simulate the normal MV function. To achieve this, it enrolled 100 individuals (both normal and insufficientMV), evaluated theirMV with 2D echocardiography and compared all geometrical characteristics between them. Finally, computational simulation, using specific and appropriate methods, was used to create the 3D model. Regarding the results, the most differences were found between subjects with normal and subjects with type III mitral insufficiency. Moreover, a 3D model of the normal MV was successfully developed. To conclude, there are specific geometrical differences among the normal and the most severe type of the insufficient MV, while 3D models of the normal MV can be developed by 2D echocardiography measurements.
DOI: 10.25402/fca.24305707
title: Using whole genome sequence findings to assess gene-disease causality in cardiomyopathy and arrhythmia patients supplementary material

description: <b>Aim: </b>The genetic etiologies of cardiomyopathies and arrhythmias have not been fully elucidated. <b>Materials & methods: </b>Research findings from genome analyses in a cardiomyopathy and arrhythmia cohort were gathered. Gene-disease relationships from two databases were compared with patient phenotypes. A literature review was conducted for genes with limited evidence. <b>Results: </b>Of 43 genes with candidate findings from 18 cases, 23.3% of genes had never been curated, 15.0% were curated for cardiomyopathies, 16.7% for arrhythmias and 31.3% for other conditions. 25.5% of candidate findings were curated for the patient’s specific phenotypewith 11.8% having definitive evidence. <i>MYH6 </i>and <i>TPCN1 </i>were flagged for recuration. <b>Conclusion: </b>Findings from genome sequencing in disease cohorts may be useful to guide gene-curation efforts.
DOI: 10.5281/zenodo.11172225
title: Consider Social Acceptability of Contentious Low-Carbon Energy Technologies
title: The case of nuclear fusion, agrivoltaics and offshore wind turbines in France

description: SSH CENTRE (Social Sciences and Humanities for Climate, Energy aNd Transport Research Excellence) is a Horizon Europe project, engaging directly with stakeholders across research, policy, and business (including citizens) to strengthen social innovation, SSH-STEM collaboration, transdisciplinary policy advice, inclusive engagement, and SSH communities across Europe, accelerating the EU’s transition to carbon neutrality. SSH CENTRE is based in a range of activities related to Open Science, inclusivity and diversity – especially with regards Southern and Eastern Europe and different career stages –  including: development of novel SSH-STEM collaborations to facilitate the delivery of the EU Green Deal; SSH knowledge brokerage to support regions in transition; and the effective design of strategies for citizen engagement in EU R&I activities. Outputs include action-led agendas and building stakeholder synergies through regular Policy Insight events.This is captured in a high-profile virtual SSH CENTRE generating and sharing best practice for SSH policy advice, overcoming fragmentation to accelerate the EU’s journey to a sustainable future.The documents uploaded here are part of WP2 whereby novel, interdisciplinary teams were provided funding to undertake activities to develop a policy recommendation related to EU Green Deal policy. Each of these policy recommendations, and the activities that inform them, will be written-up as a chapter in an edited book collection. Three books will make up this edited collection - one on climate, one on energy and one on mobility.

 The present project proposes to conduct a research on social acceptability of three controversial technologies in France: nuclear fusion, agrivoltaics and offshore wind turbines. We review the literature  and develop a framework for studying the dynamics of acceptability of these technologies over the entire 2013-2023 period. 

This file contains:



Appendix 1 : This output uploaded is the literary corpus from the EUROPRESSE database used to carry out the sentimental analysis and the topics modelling

Appendix 2 : The scraping results of the corpus from the EUROPRESSE database

Appendix 3 : The topic modeling results of the corpus from the EUROPRESSE database

Appendix 4 : The sentimental analysis results of the corpus from the EUROPRESSE database

Appendix 5 : This file  provides a comprehensive analysis of the factors shaping the social acceptability of low-carbon energy technologies in France

Appendix 6 : This file sorted the 10 most positive and the 10 most negative articles associated with each low-carbon energy technology